Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Venous Thrombosis

  Free Subscription

Articles published in Am J Hematol

Retrieve available abstracts of 13 articles:
HTML format
Text format

Single Articles

    March 2017
  1. CHEN YW, Khorana A
    The association between race and venous thromboembolism risk after initiation of chemotherapy: An analysis of the SAVE-ONCO Trial control arm.
    Am J Hematol. 2017 Mar 6. doi: 10.1002/ajh.24712.
    PubMed     Text format    

    February 2017
  2. PATELL R, Rybicki L, McCrae KR, Khorana AA, et al
    Predicting Risk Of Venous Thromboembolism In Hospitalized Cancer Patients: Utility of A Risk Assessment Tool.
    Am J Hematol. 2017 Feb 27. doi: 10.1002/ajh.24700.
    PubMed     Text format     Abstract available

    January 2017
  3. OVANESOV MV, Menis MD, Scott DE, Forshee R, et al
    Association of Immune Globulin Intravenous (IGIV) and Thromboembolic Adverse Events (TEEs).
    Am J Hematol. 2017 Jan 9. doi: 10.1002/ajh.24644.
    PubMed     Text format    

    August 2016
  4. KHANAL N, Bociek RG, Chen B, Vose JM, et al
    Venous Thromboembolism in Patients with Hematologic Malignancy and Thrombocytopenia.
    Am J Hematol. 2016 Aug 4. doi: 10.1002/ajh.24526.
    PubMed     Text format     Abstract available

    July 2016
  5. ANTIC D, Milic N, Nikolovski S, Todorovic M, et al
    Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients.
    Am J Hematol. 2016 Jul 6. doi: 10.1002/ajh.24466.
    PubMed     Text format     Abstract available

    June 2016
  6. CHALAYER E, Chapelle C, Leleu X, Elalamy I, et al
    Usual risk factors do not predict venous thromboembolism in newly diagnosed myeloma treated with immunomodulatory drugs.
    Am J Hematol. 2016 Jun 24. doi: 10.1002/ajh.24454.
    PubMed     Text format    

    May 2016
  7. ZAJA F, Barcellini W, Cantoni S, Carpenedo M, et al
    Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Am J Hematol. 2016;91:E293-5.
    PubMed     Text format     Abstract available

    March 2016
  8. AMMANN EM, Haskins CB, Fillman KM, Ritter RL, et al
    Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs.
    Am J Hematol. 2016 Mar 11. doi: 10.1002/ajh.24358.
    PubMed     Text format     Abstract available

    February 2016
  9. ANEA CB, Lyon M, Lee IA, Gonzales JN, et al
    Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease.
    Am J Hematol. 2016;91:173-8.
    PubMed     Text format     Abstract available

    September 2015
  10. FREEMAN AT, Ataga KI
    Pulmonary Endarterectomy as Treatment for Chronic Thromboembolic Pulmonary Hypertension in Sickle Cell Disease.
    Am J Hematol. 2015 Sep 15. doi: 10.1002/ajh.24192.
    PubMed     Text format    

    August 2015
  11. FOLSOM AR, Tang W, Roetker NS, Heckbert SR, et al
    Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Am J Hematol. 2015 Aug 11. doi: 10.1002/ajh.24168.
    PubMed     Text format     Abstract available

    January 2015
  12. FOLSOM AR, Olson NC, Lutsey PL, Roetker NS, et al
    American Heart Association's Life's Simple 7 and incidence of venous thromboembolism.
    Am J Hematol. 2015 Jan 21. doi: 10.1002/ajh.23950.
    PubMed     Text format    

    July 2014
  13. MARTINELLI I, De Stefano V, Carobbio A, Randi ML, et al
    Cerebral vein thrombosis in patients with philadelphia-negative myeloproliferative neoplasms. An european leukemia net study.
    Am J Hematol. 2014 Jul 19. doi: 10.1002/ajh.23809.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.